by Renovia | Jan 19, 2021 | Press Releases
Renovia names new president and CEO; completes enrollment for randomized control trial Women-led team achieves key milestone ahead of schedule Boston, Mass.—January 19, 2021—Renovia Inc. (“Renovia”), a women-led company that develops digital therapeutics for female...
by Renovia | Dec 1, 2020 | Press Releases
Renovia presents at Piper Sandler Healthcare Conference Medical Technology Disruptors Panel includes Renovia’s leva® Digital Therapeutic, a novel approach for an underreported disorder affecting 20 million women in the U.S. Boston, Mass.—December 1, 2020—Renovia Inc....
by Renovia | Nov 26, 2019 | Press Releases
Boston, MA – November 25, 2019 – Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic device and app technologies for women with pelvic floor disorders, today announced U.S. Food and Drug...
by Renovia | Aug 7, 2019 | Press Releases
Study Demonstrates Improvements in Objective Pelvic Floor Muscle Measures, Patient-Reported Urinary Incontinence Severity and Condition-Specific Quality of Life, with Results Evident after 1 Week of Use Boston, MA – August 7, 2019 – Renovia Inc. (“Renovia”), a company...
by Renovia | Mar 28, 2019 | Press Releases
Boston, MA – March 28, 2019 – Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders, today announced that it has received a nomination for MedTech Company...
by Renovia | Mar 14, 2019 | Press Releases
Boston, MA – March 14, 2019– Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders, today announced Jim O’Connor has been promoted to General Counsel...
